Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ARISTO BIO-TECH AND LIFESCIENCE LTD.

NSE : NABSE : ISIN CODE : INE082101010Industry : Pesticides & AgrochemicalsHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( ) 00

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-03 2005

Management Info

Narendra Singh Barhat - Chairman Narendra Singh Barhat - Managing Director

Registered Office

Address E-24,25,26, G. I. D. C. Manjusar,Ta. Savli, ,
Vadodara Dist,
Gujarat-391776

Phone 02667-264841 / 43

Email mail@aristobiotech.com

Website www.aristobiotech.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : NSE

NEWS

19Mar Appointment
Aristo Bio Tech And Lifescience Limited has informed the Exchange regard..

11Mar Award of Order/Contract/Project
Aristo Bio Tech And Lifescience Limited has informed the Exchange regard..

11Mar Updates
Aristo Bio Tech And Lifescience Limited has informed the Exchange regard..

13Feb Updates
Aristo Bio Tech And Lifescience Limited has informed the Exchange regard..

18Jan Award of Order/Contract/Project
Aristo Bio Tech And Lifescience Limited has informed the Exchange regard..

Financials

Rs. in Millions

	QTR	ANNUAL 23
Net Profit		35.6199999999997
Gross Profit		47.3899999999997
Operating Profit		90.2799999999997
Net Sales		2178.56

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Rasayan (BSE) 9777.00 (2.07%)	M.Cap ( in Cr)3980.25
Astec Lifesciences (BSE) 1266.85 (2.31%)	M.Cap ( in Cr)2428.01
Excel Industries (BSE) 1021.30 (1.52%)	M.Cap ( in Cr)1264.61
Bhagiradha Chem (BSE) 1924.90 (0.73%)	M.Cap ( in Cr)1988.49
PI Industries (BSE) 3760.35 (0.37%)	M.Cap ( in Cr)56841.19

Shareholding Pattern

	PROMOTERS	73.37%
	NON-INSTITUTION	26.63%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ARISTO BIO-TECH AND LIFESCIENCE LTD.